I am a bit confused by two statement in the news release. Can anyone offer a clarification?
Eutro will receive for this transaction 500,000 shares of Cypro common stock valued at $1,000,000.
Along with its other holdings and clients, its tangible assets will be increased by approximately $2,000,000.
If EUTO is getting $1,000,000 for the deal, then how are their assets increasing by $2,000,000?
In the past, when Brad talked about BIO, he said the BIO income enabled EUTO to pay it's bills. It seems to me that their reliable source of income has be sold. Any thoughts?
Judith |
